New potent inhibitors of trypanothione reductase from Trypanosoma cruzi in the 2-aminodiphenylsulfide series

European Journal of Medicinal Chemistry

Volumn 32, Issue 1, 1997, Pages 39-52

  Girault, S ^a   Baillet, S ^a   Horvath, D ^a   Lucas, V ^a   Davioud Charvet, E ^a   Tartar, A ^a   Sergheraert, C ^a  

^a CNRS   (France)

Author keywords

2 Aminodiphenylsulfide; Enzymatic inhibition; Molecular modeling; Trypanosomatid; Trypanothione reductase

Indexed keywords

ANTITRYPANOSOMAL AGENT; OXIDOREDUCTASE; TRYPANOTHIONE;

ARTICLE; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; MOLECULAR MODEL; NONHUMAN; TRYPANOSOMA CRUZI;

EID: 0031014888     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(97)84360-7     Document Type: Article

References (22)

1. 1 Fairlamb AH, Blackburn P, Ulrich P, Chait BT, Cerami A (1985) Science 27, 1485-1487
2. 2 Fairlamb AH, Cerami A (1985) Mol Biochem Parasitol 14, 187-198
3. 3 Fairlamb AH, Cerami A (1992) Annu Rev Microbiol 46, 695-729
4. 4 Henderson GB, Fairlamb AH, Ulrich P, Cerami A (1987) Biochemistry 26, 3023-3027
5. 5 Kosower EM, Radkowsky AE, Fairlamb AH, Croft SL, Neal RA (1995) Eur J Med Chem 30, 659-671
6. 6 Tromelin A, Moutiez M, Meziane-Cherif D, Aumercier M, Tartar A, Sergheraert C (1993) Bioorg Med Chem Letters 3, 1971-1976
7. 7 Garforth J, McKie JH, Jaouhari R, Benson TJ, Fairlamb AH, Douglas KT (1994) Amino Acids 6, 295-299
8. 8 Aumercier M, Mezziane-Cherif D, Moutiez M, Tartar A, Sergheraert C (1994) Anal Biochem 223, 161-164
9. 9 Baert C (1975) PhD Thesis, Faculty of Pharmacy, University of Lille II, France
10. 10 Benson TJ, McKie JH, Garforth J, Borges A, Fairlamb AH, Douglas KT (1992) Biochem J 286, 9-11
11. 11 Barioglio SR, Lacuara JL, Oliva PP (1987) J Parasitol 73, 451-452
12. 12 Croft SL, Walker JJ, Gutteridge WE (1988) Trop Med Parasitol 39, 145-148
13. 13 Hammond DJ, Cover B, Gutteridge WE (1984) Trans Soc Trop Med Hyg 78, 91-95
14. 14 Hammond DJ, Hogg J, Gutteridge WE (1985) Exper Parasitol 60, 32-42
15. 15 Goodman Gilman A (1990) Pharmacological Bases of Therapeutics (8th edition), MacGraw Hill, New York, 405-410
16. 16 Fernandez-Gomez R, Moutiez M, Aumercier M et al (1995) Int J Antimicrob Agents 6, 111-118
17. 17 Kuriyan J, Kong XP, Krishna TSR et al (1991) Proc Natl Acad Sci USA 88, 8764-8768
18. 18 Baillet S, Buisine E, Horvath D, Maes L, Bonnet B, Sergheraert C (1996) Bioorg Med Chem 4, 891-899
19. 19 Dougherty DA (1996) Science 271, 163-168
20. 20 Moutiez M, Tromelin A, Parmentier B et al (1995) Secondes Conférences Européennes du Groupement des Pharmacochimistes de l'Arc Atlantique, Caen, France
21. 21 Jacoby EM, Schlichting I, Lantwin CB, Kabsch W, Krauth-Siegel RL (1996) Proteins: Structure, Function, and Genetics 24, 73-80
22. 22 Von Arx E, Faupel M, Brugger M (1976) J Chromatography 120, 224-230